New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients ...

You might experience other health effects if you don't manage prediabetes effectively, possibly affecting your eyes, heart, ...

The following is a summary of “Racial and Ethnic Disparities at Enrollment in DRCRnet Clinical Trials for Diabetic Macular ...

Eleven children who were legally blind at birth all gained visual acuity after receiving MeiraGTx's investigational gene ...

announced that the Chinese Center for Drug Evaluation has accepted Arctic Vision's New Drug Application (NDA) for ARCATUS®, a treatment for uveitic macular edema (UME), for review. This NDA is ...

Patient discussions are crucial for tailoring IOL choices, ensuring alignment with lifestyle, needs, and surgical outcome ...

Diabetic retinopathy is the number one preventable cause of blindness. To avoid it, simply take care of your diabetes. Two ...

So far, five biosimilars that reference Eylea 2 mg have been approved by the FDA. Alvotech/Teva expect to regulatory approval ...

Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review their AVTO6 ...